* Dolby Laboratories Inc DLB.N DLB is expected to show a
fall
in quarterly revenue when it reports results on February 3.
* The San Francisco California-based company is expected to
report a 7.1% decrease in revenue to $362.222 million from
$389.87 million a year ago, according to the mean estimate from
4 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Dolby Laboratories
Inc is
for earnings of $1.06 per share. For the same quarter last year,
the company reported earnings of $1.48 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Dolby
Laboratories Inc is $113, about 22.2% above its last closing
price of $87.88.
*
This summary was machine generated February 1 at 21:56 GMT. All
figures in US dollars unless otherwise stated